{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:31:48Z","timestamp":1788571908613,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009410","name":"Southern California Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["UL1TR000124UCLA"],"award-info":[{"award-number":["UL1TR000124UCLA"]}],"id":[{"id":"10.13039\/100009410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10549-022-06581-9","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T09:18:00Z","timestamp":1649323080000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer"],"prefix":"10.1007","volume":"193","author":[{"given":"Linda","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"R\u00fcnger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hadaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlie K.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna J.","family":"Attai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-292X","authenticated-orcid":false,"given":"Maggie L.","family":"DiNome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"6581_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positivie breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455\u20131461","journal-title":"JAMA"},{"key":"6581_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M et al (2015) Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol 33:258\u2013264","journal-title":"J Clin Oncol"},{"key":"6581_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Banenfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA a prospective multicentre cohort study. Lancet Oncol 14:609\u2013618","journal-title":"Lancet Oncol"},{"key":"6581_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV et al (2014) Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg 260:608\u2013616","journal-title":"Ann Surg"},{"key":"6581_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M et al (2014) Pathologic complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384:164\u2013172","journal-title":"Lancet"},{"key":"6581_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-010-1228-x","volume":"125","author":"G von Minckwitz","year":"2011","unstructured":"von Minckwitz G, Untch M, Nuesch F et al (2011) Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials. Breast Cancer Res Treat 125:145\u2013156","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"6581_CR7","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1245\/s10434-020-08888-7","volume":"27","author":"G Montagna","year":"2020","unstructured":"Montagna G, Sevilimedu V, Fornier M, Jhaveri K, Morrow M, Pilewskie ML (2020) How effective is neoadjuvant endocrine therapy (NET) in downstaging the axilla and achieving breast-conserving surgery? Ann Surg Oncol 27(12):4702\u20134710","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"6581_CR8","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1245\/s10434-020-08905-9","volume":"27","author":"A Stafford","year":"2020","unstructured":"Stafford A, Williams A, Edmiston K, Cocilovo C, Cohen R, Bruce S et al (2020) Axillary response in patients undergoing neoadjuvant endocrine treatment for node-positive breast cancer: systematic literature review and NCDB analysis. Ann Surg Oncol 27(12):4669\u20134677","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"6581_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569\u2013575. https:\/\/doi.org\/10.1001\/jama.2011.90","journal-title":"JAMA"},{"issue":"12","key":"6581_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/s1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15(12):1303\u20131310. https:\/\/doi.org\/10.1016\/s1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"issue":"2","key":"6581_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21873\/invivo.11831","volume":"34","author":"C Cipolla","year":"2020","unstructured":"Cipolla C, Valerio MR, Grassi N et al (2020) Axillary nodal burden in breast cancer patients with pre-operative fine needle aspiration-proven positive lymph nodes compared to those with positive sentinel nodes. In Vivo 34(2):729\u2013734. https:\/\/doi.org\/10.21873\/invivo.11831","journal-title":"In Vivo"},{"issue":"2","key":"6581_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1245\/s10434-014-4071-1","volume":"22","author":"NC Verheuvel","year":"2015","unstructured":"Verheuvel NC, van den Hoven I, Ooms HW, Voogd AC, Roumen RM (2015) The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era. Ann Surg Oncol 22(2):409\u2013415. https:\/\/doi.org\/10.1245\/s10434-014-4071-1","journal-title":"Ann Surg Oncol"},{"key":"6581_CR13","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1245\/s10434-014-3813-4","volume":"21","author":"AS Caudle","year":"2014","unstructured":"Caudle AS, Kuerer HM, Le-Petross HT et al (2014) Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol 21:3440\u20133447","journal-title":"Ann Surg Oncol"},{"key":"6581_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12956-019-1582-z","author":"Y Liang","year":"2019","unstructured":"Liang Y, Chen X, Tong Y et al (2019) Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era. World J Surg Oncol. https:\/\/doi.org\/10.1186\/s12956-019-1582-z","journal-title":"World J Surg Oncol"},{"issue":"8","key":"6581_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong J-H, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567\u2013575. https:\/\/doi.org\/10.1056\/NEJMoa020128","journal-title":"N Engl J Med"},{"key":"6581_CR16","first-page":"633638","volume":"47","author":"H Johansen","year":"2008","unstructured":"Johansen H et al (2008) Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised study. Acta Oncol 47:633638","journal-title":"Acta Oncol"},{"issue":"7458","key":"6581_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0140-6736(66)92590-6","volume":"2","author":"D Brinkley","year":"1966","unstructured":"Brinkley D, Haybittle SL (1966) Treatment of stage-II carcinoma of the female breast. Lancet 2(7458):291\u2013295. https:\/\/doi.org\/10.1016\/s0140-6736(66)92590-6","journal-title":"Lancet"},{"issue":"9","key":"6581_CR18","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1245\/s10434-017-5898-z","volume":"24","author":"OA Petruolo","year":"2017","unstructured":"Petruolo OA, Pilewskie M, Patil S et al (2017) Standard pathologic features can be used to identify a subset of estrogen receptor positive, HER2 negative patients likely to benefit from neoadjuvant chemotherapy. Ann Surg Oncol 24(9):2556\u20132562","journal-title":"Ann Surg Oncol"},{"key":"6581_CR19","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","volume":"23","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Hortobagyi GN, Rouzier R et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23:9304\u20139311","journal-title":"J Clin Oncol"},{"key":"6581_CR20","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G von Minckwitz","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer JU et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30:1796\u20131804","journal-title":"J Clin Oncol"},{"key":"6581_CR21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09228-5","author":"S Angarita","year":"2020","unstructured":"Angarita S, Ye L, R\u00fcnger D et al (2020) Assessing the burden of nodal disease for breast cancer patients with clinically positive nodes: hope for more limited axillary surgery. Ann of Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-020-09228-5","journal-title":"Ann of Surg Oncol"},{"key":"6581_CR22","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09943-7","author":"A Crown","year":"2021","unstructured":"Crown A, Sevilimedu V, Morrow M (2021) Palpable adenopathy does not indicate high-volume axillary nodal disease in hormone receptor-positive breast cancer. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-021-09943-7","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"6581_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF et al (2018) Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 379(2):111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1804710","journal-title":"N Engl J Med"},{"key":"#cr-split#-6581_CR24.1","unstructured":"Kalinsky K, Barlow WE, Meric-Bernstam F, et al. (2020) SWOG S1007:adjuvant trial randomized ER+ patients who had a recurrence score < 25 and 1-3 positie nodes to endocrine therapy (ET) versus ET + chemotherapy. In: Virtual San Antonio Breast Cancer Symposium"},{"key":"#cr-split#-6581_CR24.2","unstructured":"Kalinsky K, Barlow WE, Meric-Bernstam F, et al. (2020) SWOG S1007:adjuvant trial randomized ER+ patients who had a recurrence score < 25 and 1-3 positie nodes to endocrine therapy"},{"key":"#cr-split#-6581_CR24.3","unstructured":"(ET) versus ET + chemotherapy. In: Virtual San Antonio Breast Cancer Symposium; 8-11 December 2020"},{"issue":"4","key":"6581_CR25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1245\/s10434-015-4944-y","volume":"23","author":"M Pilewskie","year":"2016","unstructured":"Pilewskie M, Mautner SK, Stempel M, Eaton A, Morrow M (2016) Does a positive axillary lymph node needle biopsy result predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era? Ann Surg Oncol 23(4):1123\u20131128. https:\/\/doi.org\/10.1245\/s10434-015-4944-y","journal-title":"Ann Surg Oncol"},{"key":"6581_CR26","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1245\/s10434-017-5935-y","volume":"24","author":"CK Harris","year":"2017","unstructured":"Harris CK, Tran HT, Lee K et al (2017) Positive ultrasound-guided lymph node needle biopsy in breast cancer may not mandate axillary lymph node dissection. Ann Surg Oncol 24:3004\u20133010","journal-title":"Ann Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06581-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06581-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06581-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T18:08:08Z","timestamp":1652206088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06581-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6581"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06581-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the UCLA Institutional Review Board and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}